Home - Melanoma Research Alliance

MRA 2019-2020 Request for Proposals - Now Available

The Melanoma Research Alliance (MRA) is pleased to announce its 2019 – 2020 Request for Proposals for preclinical, translational and early clinical research with the power to transform melanoma prevention, detection, staging, and treatment.

The 2018 - 2019 award cycle is anticipated to support at least $9 million in funding. Proposals will be accepted for Pilot, Team Science, Young Investigator, and Mid-Career Awards.

Raising the Bar: MRA’s 2018-2019 Annual Report

Inch by inch, year by year, and breakthrough by breakthrough, the melanoma field has made unprecedented progress that has transformed the way melanoma is diagnosed and treated. For many patients this progress is rewriting the book about what it means to face melanoma. However, there is still more to do.

Read the Report

Treating Melanoma Patients Before Surgery

Over 90% of patients who have their tumors surgically removed will never see their tumors come back or spread to other sites, but is there a way to prevent recurrence in those patients that will eventually go on to relapse? One approach currently being tested in clinical trials, termed neoadjuvant therapy, is to treat early stage patients with targeted or immunotherapy before surgical removal of their tumor.